Cancer News and Research

Latest Cancer News and Research

AstraZeneca receives six months pediatric exclusivity patent extension for ARIMIDEX (anastrozole)

AstraZeneca has announced that the United States (US) Food and Drug Administration (FDA) has granted an additional six-month period of exclusivity to market ARIMIDEX (anastrozole) for its licensed breast cancer indications until June 2010.

2 Dec 2007

10% of patients in NHS hospitals may experience some kind of adverse event

One in ten NHS patients comes to harm while in hospital as a result of their clinical care, suggests a study in Quality and Safety in Health Care.

2 Dec 2007

Transporters may help delay diabetes-related retinal damage

Two transporters that deliver alternative energy sources to the eye may help delay retinal damage that can occur in diabetes, researchers say.

29 Nov 2007

Stereoscopic digital mammography takes breast imaging to a new dimension

Stereoscopic digital mammography, a new diagnostic technique capable of producing three-dimensional, in-depth views of breast tissue, could significantly reduce the number of women who are recalled for additional tests following routine screening mammography.

29 Nov 2007

Queen's University Belfast opens new centre for cancer research

Queen's Chancellor Senator George Mitchell officially opened the University's new £25M cancer research centre aimed at stopping the spread of cancer.

29 Nov 2007

Potential early warning system for lung cancer identified

The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent.

29 Nov 2007

New genetic findings on malaria parasite

The malaria parasite has been studied for decades, but surprisingly, little is known about how it behaves in humans to cause disease.

29 Nov 2007

Stereo mammography improves cancer detection

A new radiological diagnostic tool called stereo mammography allows clinicians to detect more lesions and could significantly reduce the number of women who are recalled for additional tests following routine screening mammography.

29 Nov 2007

MicroRNA switches off tumor protection

The microRNA miR-21 suppresses the production of tumor suppressor Pdcd4, which protects cells from cancer development.

29 Nov 2007

Health professionals worry about ethnic sensitivity

Health professionals worry that a lack of knowledge about different cultures may lead to them being seen as insensitive or inappropriate to patients from different ethnic backgrounds - according to new research.

29 Nov 2007

Latest on research on cancer prevention

Perhaps the best way to fight cancer is to prevent it from developing in the first place.

29 Nov 2007

Scientists observe gene activity outside the body

Researchers at Jefferson Medical College and Jefferson's Kimmel Cancer Center in Philadelphia have used PET imaging to see hyperactive cancer genes inside breast tumors in laboratory animals, marking the first time such gene activity has been observed from outside the body.

29 Nov 2007

New Australian Institute will provide hope to asbestos sufferers

The institute will be operated by the Asbestos Research Foundation will be an affiliate research institute with the The University of Sydney.

29 Nov 2007

Innovative drug production project secures funding from Technology Strategy Board

PolyTherics, a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy, has announced that it has secured funding from the Technology Strategy Board.

29 Nov 2007

Genetic differences point to ethnic and racial disparities in colorectal cancer risk

Risk of developing colorectal cancer is known to differ across ethnic and racial groups, and now an analysis of 26 studies, involving over 25,000 participants shows that some of these disparities might be explained by distinct patterns of genetic inheritance.

29 Nov 2007

Effects of weight, genetics and religious beliefs on prostate cancer

African-American men face an observable disadvantage versus Caucasian men when it comes to prostate cancer survival.

29 Nov 2007

New drug, eltrombopag boosts platelets in hepatitis C patients

It's not a cure, but this may be some of the best news patients infected with the hepatitis C virus (HCV) have heard in a long time: A new drug, eltrombopag, appears to be effective in boosting low platelet counts, one of the major reasons why patients can't endure antiviral treatments.

29 Nov 2007